In this guest column, Scott Mazza, co-founder and COO of Vitality CBD, outlines three key policy changes he believes should be addressed in the 2023 Farm Bill to bring clarity and stability to the CBD market. Mazza argues for FDA approval of CBD as a dietary supplement, clear federal treatment of Delta-8 THC, and a revised THC threshold for hemp, positioning regulatory certainty as essential for consumer safety, product quality, and long-term industry growth.

In this guest column, Scott Mazza, co-founder and COO of Vitality CBD, examines what current research does—and does not—tell us about CBD salves for pain management and athletic recovery. Mazza outlines the compound’s anti-inflammatory potential, growing adoption among professional athletes, and the need for stronger clinical evidence and product standards, emphasizing third-party testing and quality controls as essential safeguards as interest in CBD-based alternatives to opioids continues to grow.

In this guest column, Scott Mazza of Vitality CBD examines the growing acceptance of CBD in professional sports following Major League Baseball’s decision to allow CBD sponsorships. Drawing on developments across the MLB, NFL, and UFC, Mazza explains why CBD aligns with athlete recovery and consumer awareness, while outlining the regulatory and advertising constraints companies must navigate as CBD enters mainstream sports media.

In this guest column, Scott Mazza of Vitality CBD explains why organic cultivation and extraction standards are critical to ensuring safe, high-quality CBD products. Drawing on research and industry testing data, Mazza details how pesticides, heavy metals, and poor extraction methods compromise product integrity, and outlines why USDA organic certification and third-party lab testing are essential safeguards for consumers seeking clean, accurately labeled hemp-derived CBD.

In this guest column, Scott Mazza, co-founder and COO of Vitality CBD, calls for stricter enforcement of third-party lab testing and quality controls in New York’s hemp-derived CBD market. Drawing on industry data and investigative findings, Mazza explains how weak compliance around potency, purity, and labeling puts consumers at risk, and argues that transparent testing, consumer pressure, and producer-led standards are essential to restoring trust and accountability in the state’s CBD ecosystem.